Literature DB >> 19819377

Cost is killing patients: subsidising effective antimalarials.

Ambrose Talisuna1, Penny Grewal, John Bosco Rwakimari, Susan Mukasa, George Jagoe, Jaya Banerji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19819377     DOI： 10.1016/S0140-6736(09)61767-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Adult and child malaria mortality in India: a nationally representative mortality survey.

Authors:  Neeraj Dhingra; Prabhat Jha; Vinod P Sharma; Alan A Cohen; Raju M Jotkar; Peter S Rodriguez; Diego G Bassani; Wilson Suraweera; Ramanan Laxminarayan; Richard Peto
Journal:  Lancet       Date:  2010-10-20       Impact factor: 79.321

Review 2.  Subsidising artemisinin-based combination therapy in the private retail sector.

Authors:  Newton Opiyo; Gavin Yamey; Paul Garner
Journal:  Cochrane Database Syst Rev       Date:  2016-03-09

3.  Cost and Predictors of Care-Seeking Behaviors Among Caregivers of Febrile Children-Uganda, 2009.

Authors:  Manoj P Menon; Joseph D Njau; Deborah A McFarland
Journal:  Am J Trop Med Hyg       Date:  2016-02-15       Impact factor: 2.345

4.  Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.

Authors:  Sandra Alba; Manuel W Hetzel; Catherine Goodman; Angel Dillip; Jafari Liana; Hassan Mshinda; Christian Lengeler
Journal:  Malar J       Date:  2010-06-15       Impact factor: 2.979

5.  The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.

Authors:  Beth P Kangwana; Sarah V Kedenge; Abdisalan M Noor; Victor A Alegana; Andrew J Nyandigisi; Jayesh Pandit; Greg W Fegan; James E Todd; Simon Brooker; Robert W Snow; Catherine A Goodman
Journal:  PLoS Med       Date:  2011-05-31       Impact factor: 11.069

6.  Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.

Authors:  Shunmay Yeung; Edith Patouillard; Henrietta Allen; Duong Socheat
Journal:  Malar J       Date:  2011-08-18       Impact factor: 2.979

7.  Social economic factors and malaria transmission in Lower Moshi, northern Tanzania.

Authors:  Asanterabi Lowassa; Humphrey D Mazigo; Aneth M Mahande; Beda J Mwang'onde; Shandala Msangi; Michael J Mahande; Epiphania E Kimaro; Eliapenda Elisante; Eliningaya J Kweka
Journal:  Parasit Vectors       Date:  2012-06-28       Impact factor: 3.876

8.  Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania.

Authors:  Prashant Yadav; Jessica L Cohen; Sarah Alphs; Jean Arkedis; Peter S Larson; Julius Massaga; Oliver Sabot
Journal:  Malar J       Date:  2012-08-28       Impact factor: 2.979

9.  Understanding the impact of subsidizing artemisinin-based combination therapies (ACTs) in the retail sector--results from focus group discussions in rural Kenya.

Authors:  Sarah V Kedenge; Beth P Kangwana; Evelyn W Waweru; Andrew J Nyandigisi; Jayesh Pandit; Simon J Brooker; Robert W Snow; Catherine A Goodman
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study.

Authors:  Ambrose O Talisuna; Penny Grewal Daumerie; Andrew Balyeku; Timothy Egan; Bram Piot; Renia Coghlan; Maud Lugand; Godfrey Bwire; John Bosco Rwakimari; Richard Ndyomugyenyi; Fred Kato; Maria Byangire; Paul Kagwa; Fred Sebisubi; David Nahamya; Angela Bonabana; Susan Mpanga-Mukasa; Peter Buyungo; Julius Lukwago; Allan Batte; Grace Nakanwagi; James Tibenderana; Kinny Nayer; Kishore Reddy; Nilesh Dokwal; Sylvester Rugumambaju; Saul Kidde; Jaya Banerji; George Jagoe
Journal:  Malar J       Date:  2012-10-29       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.